Pharma-Bio Serv, Inc.
PBSV · OTC
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Revenue | $10 | $17 | $19 | $20 |
| % Growth | -44% | -12.5% | -3.6% | – |
| Cost of Goods Sold | $7 | $12 | $15 | $15 |
| Gross Profit | $3 | $5 | $5 | $5 |
| % Margin | 26.5% | 29.8% | 25.2% | 26.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $4 | $4 | $4 | $9 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $4 | $4 | $4 | $9 |
| Operating Income | -$1 | $1 | $1 | -$4 |
| % Margin | -13.5% | 6.6% | 6.1% | -19.2% |
| Other Income/Exp. Net | $1 | $1 | $0 | $2 |
| Pre-Tax Income | -$1 | $2 | $1 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | $1 | $1 | -$2 |
| % Margin | -8.2% | 7.7% | 5.2% | -10.4% |
| EPS | -0.034 | 0.057 | 0.044 | -0.091 |
| % Growth | -159.5% | 30.1% | 148.3% | – |
| EPS Diluted | -0.034 | 0.057 | 0.044 | -0.091 |
| Weighted Avg Shares Out | 23 | 23 | 23 | 23 |
| Weighted Avg Shares Out Dil | 23 | 23 | 23 | 23 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | $1 | $1 | -$4 |
| % Margin | -11.6% | 7.7% | 6.3% | -18.8% |